It was found that IL-25 inhibited Th17 cell responses via reduction of IL-17A levels and ROR-γt gene expression in PBMCs from patients with RA (Liu et al., 2016; Lavocat et al., 2017). The gene discussed is IL17A; the disease is rheumatoid arthritis.